Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William W B Wang

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|June 1, 2005
Correlation coefficient inference on censored bioassay dataLiang Li, William W B Wang, Ivan S F Chan
Journal of Biopharmaceutical Statistics|March 23, 2023
Application of estimand framework in ICH E9 (R1) to safety evaluationXuelong Wang, Ping Yang, Shuai S Yuan, et al.
Journal of Biopharmaceutical Statistics|June 6, 2024
Application of estimand framework to the design and analysis of multi-regional clinical trialsCuizhen Niu, Liwen Liang, Rong Fu, et al.
Journal of Biopharmaceutical Statistics|September 6, 2012
A predictive Bayesian approach to the design and analysis of bridging studiesA Lawrence Gould, Tian Jin, Li Xin Zhang, et al.
Journal of Biopharmaceutical Statistics|April 4, 2023
Application of estimand framework in ICH E9 (R1) to vaccine trialsRong Fu, Hal Li, Xuelong Wang, et al.
Journal of Biopharmaceutical Statistics|March 11, 2011
Handling missing data in vaccine clinical trials for immunogenicity and safety evaluationXiaoming Li, William W B Wang, Guanghan F Liu, et al.
Contemporary Clinical Trials|June 27, 2021
Estimation of causal effect in integrating randomized clinical trial and observational data - An example application to cardiovascular outcome trialYafei Zhang, Li-An Lin, Liis Starkopf, et al.
Contemporary Clinical Trials|October 22, 2020
Bayesian hierarchical model for safety signal detection in multiple clinical trialsYafei Zhang, Shuai Sammy Yuan, Barry A Eagel, et al.
Clinical and Vaccine Immunology : CVI|March 6, 2009
Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or olderSantosh C Sutradhar, William W B Wang, Katia Schlienger, et al.
Journal of Patient-Reported Outcomes|April 11, 2026
Missing data considerations for patient reported outcome measures in randomized controlled trialsFan Wang, Shenran Deng, Jing Sun, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|June 1, 2005
Correlation coefficient inference on censored bioassay dataLiang Li, William W B Wang, Ivan S F Chan
Journal of Biopharmaceutical Statistics|March 23, 2023
Application of estimand framework in ICH E9 (R1) to safety evaluationXuelong Wang, Ping Yang, Shuai S Yuan, et al.
Journal of Biopharmaceutical Statistics|June 6, 2024
Application of estimand framework to the design and analysis of multi-regional clinical trialsCuizhen Niu, Liwen Liang, Rong Fu, et al.
Journal of Biopharmaceutical Statistics|September 6, 2012
A predictive Bayesian approach to the design and analysis of bridging studiesA Lawrence Gould, Tian Jin, Li Xin Zhang, et al.
Journal of Biopharmaceutical Statistics|April 4, 2023
Application of estimand framework in ICH E9 (R1) to vaccine trialsRong Fu, Hal Li, Xuelong Wang, et al.
Journal of Biopharmaceutical Statistics|March 11, 2011
Handling missing data in vaccine clinical trials for immunogenicity and safety evaluationXiaoming Li, William W B Wang, Guanghan F Liu, et al.
Contemporary Clinical Trials|June 27, 2021
Estimation of causal effect in integrating randomized clinical trial and observational data - An example application to cardiovascular outcome trialYafei Zhang, Li-An Lin, Liis Starkopf, et al.
Contemporary Clinical Trials|October 22, 2020
Bayesian hierarchical model for safety signal detection in multiple clinical trialsYafei Zhang, Shuai Sammy Yuan, Barry A Eagel, et al.
Clinical and Vaccine Immunology : CVI|March 6, 2009
Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or olderSantosh C Sutradhar, William W B Wang, Katia Schlienger, et al.
Journal of Patient-Reported Outcomes|April 11, 2026
Missing data considerations for patient reported outcome measures in randomized controlled trialsFan Wang, Shenran Deng, Jing Sun, et al.
Pageof 2